Skip to Main Content

Paper Details

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer.
Clin Cancer Res
15
2021
AR, Androgens, CRPC, Castration-Resistant Prostate Cancer, DHEAS, Men, PSA, PTEN, Patients, Testosterone, WT, abiraterone acetate, androgen, androgen receptor, androgens, castration-resistant prostate cancer, dehydroepiandrosterone sulfate, mCRPC, men, metastatic castration-resistant prostate cancer, patients, prednisone, steroid, testosterone, tumor, wild-type
Author NameAffiliation
Elahe A MostaghelEducation and Clinical Center (GRECC)
Elahe A MostaghelUniversity of Washington
Elahe A MostaghelFred Hutchinson Cancer Research Center
Evan Y YuUniversity of Washington
Evan Y YuFred Hutchinson Cancer Research Center
Heather H ChengUniversity of Washington
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
Steven P BalkBeth Israel Deaconess Medical Center
Mary-Ellen TaplinDana-Farber Cancer Institute, Harvard Medical School
Alvin M MatsumotoEducation and Clinical Center (GRECC)
Alvin M MatsumotoUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Bruce MontgomeryUniversity of Washington
Bruce MontgomeryFred Hutchinson Cancer Research Center
Bruce Montgomery
  • 1 - 17

Datasets

Release 1.2